In 2015, Sisili acquired Novex Pharmaceuticals Pvt. Ltd. to enter the pharmaceutical market in Sri Lanka. With local partnerships with agencies (such as Intas Pharmaceuticals Limited, India and ‘SK+F’, Bangladesh) and with a business experience of
over 12 years in the pharmaceutical industry in Sri Lanka, Novex served as the right partner for Sisili to take a step
closer towards becoming a major healthcare company.
Sisili Novex intends on focus on niche areas (for eg: Oncology and Bio-‐Tec products) to deliver quality products together with
a highly personalized customer service to our clients. Utilizing existing warehousing facilities and distributor networks, Sisili Novex has already begun catering to major clients such as the State Pharmaceuticals Corporation and the National Cancer Institute (Maharagama). In the long term, Sisili Novex is also exploring opportunities and feasibilities in establishing local manufacturing facilities for drugs identified as national priorities under the “Import – Substitution Programme” by the Government of Sri Lanka.